The global hemostasis products market is led by market players Ethicon, Baxter International, Inc., CR Bard, Inc., and Pfizer Inc., which collectively accounted for 41% of the total market share. The market is fragmented and various small and medium scale companies held 59% of the market, as of 2015. Some of these players are: HemCon Medical Technologies, Inc., CSL Behring LLC, Abbott Laboratories, Grifols, S.A., Johnson & Johnson, Medtronic plc., and Integra LifeSciences Corporation. Most of the small and medium scale players in the market are providing non-commercial variations of hemostasis products such as frozen plasma or platelet concentrate, Transparency Market Research states in its new study. Other prominent players are adopting the strategy of investing in research and development so as to expand their businesses across those regional markets, which are presently untapped.